New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
06:12 EDTAAPL, INTC, MSFT, THLD, AMGN, GSK, TM, NSANY, HMC, VLKAY, FIATY, F, GMOn the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: As U.S. companies hold near record amounts of cash, many are surprisingly cash poor at home. That means there could be unseen limits on their ability to pay dividends and buy back shares, the Wall Street Journal reports...In November, U.S. sales of cars and light trucks were the strongest in over four years, jumping 15% to 1.14M compared with a year ago. The seasonally adjusted annualized sales rate was 15.5M, the highest since January 2008, according to Autodata, the Wall Street Journal reports...REUTERS: Fed bankers appear satisfied with their latest monetary stimulus, but there's some disagreement over how strongly to continue purchasing bonds. Boston Fed President Rosengren said there was a "strong case" for the Fed to stay the course, while St. Louis Fed President Bullard said they shouldn’t replace its expiring 'Operation Twist' program on a dollar-for-dollar basis, Reuters reports...U.S. rail and trucking companies are making big investments on both sides of the border with Mexico to capitalize on booming trade between the two countries, Reuters reports...BLOOMBERG: Four experimental cancer treatments that may one day help gravely ill children are facing review by U.S. pediatric advisers. The medicines from GlaxoSmithKline (GSK), Amgen (AMGN) Threshold (THLD) and Boehringer Ingelheim have the potential to treat children with a variety of tumors and fast-spreading leukemia, Bloomberg reports...The move by Microsoft (MSFT) and Intel (INTC) to combat Apple’s (AAPL) iPad in the $63.2B tablet market is getting off to a slow start, Bloomberg reports.
News For GM;F;FIATY;VLKAY;HMC;NSANY;TM;GSK;AMGN;THLD;MSFT;INTC;AAPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | all recent news | >>
October 8, 2014
11:45 EDTAAPLApple 'surprised' by GT Advanced's Chapter 11 filing, WSJ reports
Apple (AAPL) says it was "surprised" by GT Advanced's (GTAT) Chapter 11 bankruptcy filing on Monday, the Wall Street Journal reports. Apple says it is focused on preserving jobs in Arizona and will continue to work with state and local officials "as we consider our next steps." GT Advanced is a partner for Apple's sapphire initiative. Reference Link
11:41 EDTAAPLJ.C. Penney says store base count 'roughly' where it needs to be
Says evaluating stores to see if EBITDA accretive. Says "disciplined" regarding promotions. Says won't risk margin over promotions. Says Apple (AAPL), Samsung (SSNLF), Amazon (AMZN) taking "chunk" out of consumer spending. Sees returning to 37%-39% gross margins over time.
10:44 EDTAAPLFitbit said it has no plans to integrate with iOS 8 Heath app, 9to5Mac says
Subscribe for More Information
10:33 EDTFFord falls to fresh 52-week low, levels to watch
The shares are down 2% at time of writing to $13.82, just above the fresh 52-week low set earlier today at $13.76. Support below today's low is at $13.36. Resistance is at the session high at $14.10.
10:20 EDTAMGNAmgen biosimilar franchise underappreciated, says Piper Jaffray
After Amgen announced positive Phase 3 results for its biosimilar Humira in psoriasis, Piper Jaffray said it believes that Amgen's overall pipeline is underappreciated since the company's biosimilar franchise is generally not included in consensus estimates. The firm views Amgen as a top large cap picks and reiterate its Overweight rating on the stock.
10:01 EDTHMCSolarCity and Honda renew partnership to fund $50M in solar projects
Subscribe for More Information
10:00 EDTINTCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:57 EDTAAPLBlog reveals next-generation Apple iPad Air, 9to5Mac says
Subscribe for More Information
09:38 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:16 EDTAMGNAmgen's ABP 501 for psoriasis shows positive Phase 3 results
Subscribe for More Information
08:20 EDTAAPLQualcomm opportunity at Xiaomi almost rivals iPhone, says FBR Capital
Subscribe for More Information
07:19 EDTAMGNCBI to hold a conference
Subscribe for More Information
07:11 EDTAMGNEuropean Academy of Dermatology and Venereology to hold a conference
23rd EADV Congress is being held in Amsterdam, The Netherlands on October 8-12.
06:57 EDTAAPLApple's iPhone 6 Plus more popular than iPhone 6, WantChinaTimes says
Subscribe for More Information
06:37 EDTFIATYFiat head aims to step down from post after 2018, Bloomberg says
Subscribe for More Information
06:34 EDTFIATYFiat boss expects Chrysler deal to make new No.1 vehicle maker, Bloomberg says
Subscribe for More Information
06:13 EDTAAPL, MSFTNon-Apple notebook, tablet demand to be weak till 2Q15, DigiTimes reports
Demand for non-Apple (AAPL) notebooks and tablets may remain weak until the second quarter of 2015, reports DigiTimes. Citing Taiwan makers, the pressure due to booming sales from Apple products may decrease sales until Microsoft (MSFT) launches Windows 10 next year. Demand for Samsung (SSNLF), Sony (SNE) , And HTC smartphones have also dropped worldwide recently. Reference Link
06:11 EDTGSKNovartis says expects three executive committee members to leave
Novartis (NVS) confirmed that following completion of the transactions with GlaxoSmithKline (GSK) and Eli Lilly and Company (LLY) in the coming months, that the three business leaders of the Novartis divisions at the center of the transaction will leave the Executive Committee of Novartis. The expected changes to the ECN are subject to the closing of the transactions announced on April 22 - Novartis expects the transaction with GSK to be completed in the first half of 2015, and the transaction with Eli Lilly for its Animal Health Business to close in the first quarter of 2015. George Gunn, currently Division Head, Novartis Animal Health, will reach his contractual retirement age in July 2015 and will retire from Novartis. Upon closing of the Animal Health transaction with Lilly he will leave the ECN. Brian McNamara, currently Division Head, Novartis OTC, will transition to GSK as Head of Americas and Europe for the consumer health businesses, reporting to the President of GSK Consumer Healthcare, effective at closing of the transaction. Andrin Oswald, currently Division Head, Novartis Vaccines, will be leaving Novartis to pursue other opportunities following closing of the transaction with GSK.
06:10 EDTAAPLQuantom begins small-volume production of 12-inch Macbook Air, DigiTimes says
Subscribe for More Information
05:54 EDTAAPLTeen interest in Apple Watch 'tepid,' says Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use